This page has some broken links, due to some issues with our hosting company. The issues should be fixed soon.—–
We have several pages related to the U.S. Bayh-Dole Act here.
KEI efforts to address pricing and other public interest issues in more than 22 different NIH licensing cases, involving both patents and data rights, are here: http://keionline.org/nih-licenses
Our work on the Sanofi/Army Zika vaccine license is here. https://keionline.org/zika-army
Xtandi is an Army and NIH funded invention, patented by UCLA. Our work on the efforts to get the Army or the NIH to use their march-in or royalty free license rights to obtain lower prices are collected here: https://keionline.org/xtandi
The work on government funded CRISPR inventions is here: http://keionline.org/crispr
The Fabrazyme patent disputes are here: https://keionline.org/fabry
The 2004 and 2012 ritonavir cases are here: https://keionline.org/ritonavir
Many of the other disputes and commentary on government funded inventions are listed below.